B M Baron

1.3k total citations
21 papers, 1.1k citations indexed

About

B M Baron is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, B M Baron has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 12 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in B M Baron's work include Neuroscience and Neuropharmacology Research (11 papers), Chemical Synthesis and Analysis (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). B M Baron is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Chemical Synthesis and Analysis (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). B M Baron collaborates with scholars based in United States. B M Baron's co-authors include Barry W. Siegel, Francis P. Miller, Mark W. Dudley, Deborah R. McCarty, Ian A. McDonald, S.M. Sorensen, Timothy W. Lovenberg, Timothy C. McCloskey, Francesco G. Salituro and John H. Kehne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Stroke and Journal of Medicinal Chemistry.

In The Last Decade

B M Baron

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B M Baron United States 15 767 575 162 127 96 21 1.1k
Marie‐Bernadette Assié France 19 765 1.0× 500 0.9× 139 0.9× 208 1.6× 77 0.8× 25 1.1k
T.P. Blackburn United States 14 839 1.1× 615 1.1× 103 0.6× 137 1.1× 104 1.1× 18 1.2k
Ian A. Pullar United Kingdom 21 592 0.8× 469 0.8× 177 1.1× 118 0.9× 95 1.0× 38 1.1k
Stephen M. Sorensen United States 14 487 0.6× 278 0.5× 176 1.1× 131 1.0× 81 0.8× 19 816
H Rosengarten United States 18 693 0.9× 488 0.8× 63 0.4× 187 1.5× 85 0.9× 34 1.2k
David L. Willins United States 13 1.1k 1.4× 740 1.3× 92 0.6× 104 0.8× 140 1.5× 14 1.3k
Vicky Holland United Kingdom 11 584 0.8× 369 0.6× 125 0.8× 99 0.8× 156 1.6× 13 988
Penny G. Threlkeld United States 18 752 1.0× 428 0.7× 102 0.6× 183 1.4× 109 1.1× 23 1.2k
Deborah K. Hyslop United States 12 515 0.7× 324 0.6× 93 0.6× 122 1.0× 106 1.1× 19 900
Brenda Trail United Kingdom 11 716 0.9× 432 0.8× 77 0.5× 88 0.7× 123 1.3× 15 975

Countries citing papers authored by B M Baron

Since Specialization
Citations

This map shows the geographic impact of B M Baron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B M Baron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B M Baron more than expected).

Fields of papers citing papers by B M Baron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B M Baron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B M Baron. The network helps show where B M Baron may publish in the future.

Co-authorship network of co-authors of B M Baron

This figure shows the co-authorship network connecting the top 25 collaborators of B M Baron. A scholar is included among the top collaborators of B M Baron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B M Baron. B M Baron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinkel, R. Philip, Jack H. Simon, & B M Baron. (1999). Bimonthly cranial MRI activity following an isolated monosymptomatic demyelinating syndrome: potential outcome measures for future multiple sclerosis `prevention' trials. Multiple Sclerosis Journal. 5(5). 307–312. 3 indexed citations
2.
Jiang, Ning, et al.. (1996). Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat. Journal of the Neurological Sciences. 138(1-2). 36–41. 7 indexed citations
3.
Baron, B M, et al.. (1996). [3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site.. Journal of Pharmacology and Experimental Therapeutics. 279(1). 62–68. 45 indexed citations
4.
Kehne, John H., B M Baron, Boyd L. Harrison, et al.. (1995). MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles. European Journal of Pharmacology. 284(1-2). 109–118. 32 indexed citations
5.
Hasegawa, Yasuhiro, et al.. (1994). The competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke.. Stroke. 25(6). 1241–1244. 21 indexed citations
6.
Erlander, MG, Timothy W. Lovenberg, B M Baron, Luı́s de Lecea, & J G Sutcliffe. (1993). Molecular Approach to Hypothalamic Rhythms: Isolation of Novel Indoleamine Receptor Genes. Journal of Biological Rhythms. 8(1_suppl). 25–31. 2 indexed citations
7.
Lovenberg, Timothy W., Mark G. Erlander, B M Baron, & J G Sutcliffe. (1993). Cloning of new 5-HT receptors. International Clinical Psychopharmacology. 8. 19–24. 15 indexed citations
8.
Erlander, MG, Timothy W. Lovenberg, B M Baron, et al.. (1993). Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain.. Proceedings of the National Academy of Sciences. 90(8). 3452–3456. 138 indexed citations
9.
Lovenberg, Timothy W., MG Erlander, B M Baron, et al.. (1993). Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes.. Proceedings of the National Academy of Sciences. 90(6). 2184–2188. 69 indexed citations
10.
Boeijinga, Peter H., et al.. (1992). Characterization of the novel 5-HT3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma × glioma cells. European Journal of Pharmacology. 219(1). 9–13. 59 indexed citations
11.
Baron, B M, Ian A. McDonald, B.S. Meldrum, et al.. (1992). Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.. Journal of Pharmacology and Experimental Therapeutics. 262(3). 947–956. 40 indexed citations
12.
Hurt, Stephen D. & B M Baron. (1991). [3H] 5,7-Dichlorokynurenic Acid, a High Affinity Ligand for the NMDA Receptor Glycine Regulatory Site. Journal of Receptor Research. 11(1-4). 215–220. 7 indexed citations
13.
Reynolds, Ian J., B M Baron, & M. L. EDWARDS. (1991). 1,10-bis(guanidino)decane inhibits N-methyl-D-aspartate responses in vitro and in vivo.. Journal of Pharmacology and Experimental Therapeutics. 259(2). 626–632. 10 indexed citations
14.
15.
Baron, B M, Francis P. Miller, Ian A. McDonald, et al.. (1990). Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site.. Molecular Pharmacology. 38(4). 554–561. 96 indexed citations
16.
Baron, B M & Barry W. Siegel. (1990). p-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors.. Molecular Pharmacology. 38(3). 348–356. 29 indexed citations
17.
Kane, John M., et al.. (1990). 2,4-Dihydro-3H-1,2,4-triazol-3-ones as anticonvulsant agents. Journal of Medicinal Chemistry. 33(10). 2772–2777. 88 indexed citations
18.
Palfreyman, Michael G., Francis P. Miller, John M. Kane, et al.. (1990). MDL 27,266: A broad spectrum anticonvulsant triazol-3-one. European Journal of Pharmacology. 183(2). 600–601. 2 indexed citations
19.
Salituro, Francesco G., et al.. (1990). 3-(2-Carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex. Journal of Medicinal Chemistry. 33(11). 2944–2946. 38 indexed citations
20.
Baron, B M, Mark W. Dudley, Deborah R. McCarty, et al.. (1989). Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.. Journal of Pharmacology and Experimental Therapeutics. 250(1). 162–169. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Bernadette Assié Breakdown of academic impact, for papers by T.P. Blackburn Breakdown of academic impact, for papers by Ian A. Pullar Breakdown of academic impact, for papers by Stephen M. Sorensen Breakdown of academic impact, for papers by H Rosengarten Breakdown of academic impact, for papers by David L. Willins Breakdown of academic impact, for papers by Vicky Holland Breakdown of academic impact, for papers by Penny G. Threlkeld Breakdown of academic impact, for papers by Deborah K. Hyslop Breakdown of academic impact, for papers by Brenda Trail
Rankless by CCL
2026